Lipids & Metabolic

People diagnosed with type 2 diabetes at 40 or younger were about twice as likely to die over 5.6 years of follow-up compared to age-matched controls, according to a registry study from Sweden. But the relationship weakened substantially as the age of onset progressed, such that patients diagnosed in their 80s carried no excess mortality risk.

Medtronic has struck a value-based agreement with Blue Cross and Blue Shield of Minnesota in which the medical device company will pay back the insurer if patients using the Guardian Connect continuous glucose monitoring (CGM) system fail to keep their blood sugar levels within a specified range.

Dietary risk factors—such as consuming too much sodium or not enough whole grains and fruits—were responsible for 11 million deaths globally in 2017, according to a new analysis in The Lancet.

Rare protein-truncating variants in the apolipoprotein B (APOB) gene are linked to lower triglycerides and LDL cholesterol levels and also appear to be protective against coronary heart disease (CHD), according to a study published in Circulation: Genomic and Precision Medicine.

Diabetics enrolled in certain drug benefits plans through Cigna and Express Scripts could see their out-of-pocket costs for insulin capped at $25 per month, according to an April 3 announcement. But one diabetes advocate called the move "a stopgap at best" and said it doesn't address the larger issue of sky-high list prices.

The American Diabetes Association (ADA) issued updates to its 2019 Standards of Medical Care in Diabetes on March 27 in light of recent evidence surrounding icosapent ethyl and dapagliflozin.

Nearly 60 percent of patients who met guideline-based criteria for statin therapy but weren’t taking the cholesterol-lowering drugs said they were never offered one, according to a study published March 27 in the Journal of the American Heart Association.

The American Heart Association (AHA) and the American Academy of Pediatrics (AAP) issued a joint policy statement March 25 recommending a series of public health measures aimed at reducing children’s consumption of sugary beverages.

NEW ORLEANS — A new analysis considering not only a patient's first cardiovascular event—but the second, third and beyond—paints the REDUCE-IT trial in an even more positive light. 

The CDC has released a new fact sheet on the burden of chronic kidney disease (CKD) in the U.S., highlighting its relationship to cardiovascular disease and noting that 15 percent of American adults—or 37 million people—have CKD.

A smartphone’s camera and flashlight features can detect changes in blood flow and identify type 2 diabetes with accuracy comparable to traditional, clinic-based risk scores, new research suggests.

Drug manufacturer Eli Lilly plans to offer a half-priced version of its insulin medication Humalog, the company announced March 4.